• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Rocket Pharmaceuticals, Inc. - Common Stock (NQ:RCKT)

    4.250 +0.260 (+6.52%)
    Streaming Delayed Price Updated: 4:00 PM EST, Feb 24, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,111,274
    Open 4.020
    Bid (Size) 4.230 (200)
    Ask (Size) 4.330 (900)
    Prev. Close 3.990
    Today's Range 4.020 - 4.260
    52wk Range 2.190 - 10.62
    Shares Outstanding 65,837,894
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
    From Rocket Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
    From Rocket Pharmaceuticals, Inc.
    Via Business Wire

    Performance

    YTD
    +22.8%
    +22.8%
    1 Month
    +17.1%
    +17.1%
    3 Month
    +40.3%
    +40.3%
    6 Month
    +20.1%
    +20.1%
    1 Year
    -57.7%
    -57.7%

    More News

    Read More
    News headline image
    Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference
    From Rocket Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Helmerich and Payne, Invivyd, Home Depot And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Rocket Pharmaceuticals Inc (NASDAQ:RCKT) Posts Narrower Q3 2025 Loss, Advances Gene Therapy Pipeline ↗
    Via Chartmill
    News headline image
    Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
    From Rocket Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    FDA's Rigid Approach Adds Uncertainty To uniQure's Accelerated Pathway For Huntington's Gene Therapy ↗
    Via Benzinga
    News headline image
    ROCKET ALERT: Bragar Eagel & Squire, P.C. is Investigating Rocket Pharmaceuticals, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    FDA Acceptance Of Rocket Pharmaceuticals' Lead Gene Therapy Application Reestablishes Momentum For Stock ↗
    Via Benzinga
    News headline image
    Domino's Pizza Posts Upbeat Results, Joins Astria Therapeutics, Albertsons Companies, Polaris And Other Big Stocks Moving Higher On Tuesday ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Rocket Pharmaceuticals Announces FDA Acceptance of BLA Resubmission of KRESLADI™ for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I)
    From Rocket Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Rocket Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Rocket Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Rocket Pharma Stock Gets A Price Target Cut After Withdrawing FDA Application For Rare Bone Marrow Disorder Gene Therapy ↗
    Via Stocktwits
    News headline image
    FDA Outlines Process To Speed Up Rare Disease Therapy Approvals ↗
    Via Benzinga
    News headline image
    Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
    From Rocket Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Coty, Bilibili, Canadian Solar And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Why Nordson Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Which stocks are experiencing notable movement on Wednesday? ↗
    Via Chartmill
    News headline image
    Citi Believes FDA May Closely Watch Sarepta’s Safeguards For Gene Therapy In Non-Ambulatory DMD Patients ↗
    Via Stocktwits
    Topics Death
    News headline image
    Traders are paying attention to the gapping stocks in Wednesday's session. ↗
    Via Chartmill
    News headline image
    TJX Posts Better-Than-Expected Earnings, Joins Rocket Pharmaceuticals, Guess? And Other Big Stocks Moving Higher On Wednesday ↗
    Via Benzinga
    News headline image
    FDA Lifts Rocket Pharmaceuticals Study Hold For Rare Disease Gene Therapy ↗
    Via Benzinga
    News headline image
    Wednesday's pre-market session: top gainers and losers ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga

    Frequently Asked Questions

    Is Rocket Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Rocket Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Rocket Pharmaceuticals, Inc. - Common Stock trade on?
    Rocket Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Rocket Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Rocket Pharmaceuticals, Inc. - Common Stock is RCKT on the Nasdaq Stock Market
    What is the current price of Rocket Pharmaceuticals, Inc. - Common Stock?
    The current price of Rocket Pharmaceuticals, Inc. - Common Stock is 4.250
    When was Rocket Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Rocket Pharmaceuticals, Inc. - Common Stock was at 02/24/26 04:00 PM ET
    What is the market capitalization of Rocket Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Rocket Pharmaceuticals, Inc. - Common Stock is 279.81M
    How many shares of Rocket Pharmaceuticals, Inc. - Common Stock are outstanding?
    Rocket Pharmaceuticals, Inc. - Common Stock has 280M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.